Freestone Grove Partners’s Omega Healthcare OHI Stock Holding History

Freestone Grove Partners’s Portfolio OHI Stock Details OHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-218,433	Closed	-$8.01M	–	849
2025 Q2	$8.01M	Buy	+218,433	New	+$8.11M	0.06%	299

Other funds holding OHI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Freestone Grove Partners's OHI Position: Q3 2025 in Review

Freestone Grove Partners sold out of Omega Healthcare (OHI) in Q3 2025, closing a stake of 218,433 shares — an estimated $8.01M sold.

Freestone Grove Partners first reported a position in OHI in Q2 2025 and held it in 1 quarter. The position peaked at $8.01M in Q2 2025. 681 funds tracked by Wall St. Rank hold OHI as of Q3 2025.

Freestone Grove Partners reported no remaining Omega Healthcare position as of Q3 2025 after selling out during the quarter.
Freestone Grove Partners sold 218,433 Omega Healthcare shares in Q3 2025, an estimated $8.01M.
Freestone Grove Partners first reported a position in Omega Healthcare in Q2 2025 and held it in 1 quarter.
Freestone Grove Partners's Omega Healthcare position peaked at $8.01M in Q2 2025.
681 funds tracked by Wall St. Rank held Omega Healthcare as of Q3 2025.

Based on Freestone Grove Partners's 13F filing for Q3 2025, filed 14 Nov 2025.